| CYP2J2 |
| LOCUS ID | 1573 | |||||
| GENE_SYMBOL | CYP2J2 | |||||
| GENE NAME | cytochrome P450, family 2, subfamily J, polypeptide 2 | |||||
| SYNONYMNS | CPJ2 | |||||
| CHROMOSOME | 1 | |||||
| HOMOLOGENE ID | 68091 | |||||
| SOURCE | MICE |
| PMIDs | 23696562 |
| GENE SUMMARY |
|---|
| This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is thought to be the predominant enzyme responsible for epoxidation of endogenous arachidonic acid in cardiac tissue. Multiple transcript variants have been found for this gene. [provided by RefSeq, Jan 2016] |
| OBSERVATION |
|---|
| 1. CYP2J2 epoxygenase metabolites likely play an important role in plasma glucose homeostasis, and enhancement of epoxyeicosatrienoic acids activation may serve as an effective therapeutic strategy to prevent diabetic cardiomyopathy.CYP2J2 overexpression attenuated myocardial hypertrophy induced by diabetes. We conclude that cardiac-specific overexpression of CYP2J2 significantly protects against diabetic cardiomyopathy, which may be due to improved cardiac insulin resistance, glucose uptake, and reversal of cardiac hypertrophy. |